Controlled Release Drug Delivery Market (By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-modulated Drug Delivery Systems [Osmotic Pressure Activated, Hydrodynamic Pressure Activated, Vapor Pressure Activated, Mechanically Activated, Magnetically Activated], Chemically Activated [pH Activated, Hydrolysis Activated, Enzyme Activated]; By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Others; By Application: Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-drug delivery Systems, Drug Eluting Stents) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global controlled release drug delivery market size projected to register around USD 91.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period. The market is driven by increasing technology spending in healthcare sector.

Market Dynamics

Soaring demand for pediatric and geriatric controlled release delivery methods and substitute therapies and increasing consciousness about advantages of these systems over conventional forms are providing a fillip to the controlled release drug delivery market market.

These technologies deliver numerous advantages over old-style delivery forms. Uniform drug effect, reduced dosage and less gastrointestinal side effects, dosage frequency, enhanced patient compliance, improved drug efficacy & safety, and reduced fluctuation of plasma drug levels are some of the advantages delivered by these technologies.

Market Insights

Controlled release drug delivery systems permit reduction in quantity of dose and dose frequency, increased patient compliance and acceptance, less fluctuation in plasma drug levels, uniform drug result, and improved effectualness quantitative relation of administered therapeutic. as compared to traditional delivery, these systems accomplish a chronic therapeutic result, increase foregone conclusion in drug unleash dynamics, and produce concerning delivery at a pre-determined rate regionally or consistently. Thus, with many more blessings offered by these systems, their adoption is slated to extend at a motivating rate over the approaching years.

Market Segmentation

Market By Release Mechanism

  • Polymer Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
    • Osmotic Pressure Activated
    • Hydrodynamic Pressure Activated
    • Vapor Pressure Activated
    • Mechanically Activated
    • Magnetically Activated
  • Chemically Activated
    • pH Activated
    • Hydrolysis Activated
    • Enzyme Activated

Market By Technology

  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Others

Market By Application

  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Infusion Pumps
  • Oral Controlled-drug delivery Systems
  • Drug Eluting Stents

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America captures the largest revenue share at 35.6% and will continue to retain its dominance position over the forthcoming years. Speedy acceptance of advanced devices and technologies and high per capita healthcare expenditure are expected to surge the need for connected drug delivery systems in the region. High price of controlled release drug delivery is expected to be the one of the substantial factor in hampering the market growth in emerging regions such as MEA, APAC and Latin America. Though, with the growing numeral of market entrants the device prices are anticipated to fall over time; this will backing the market growth in emerging such countries such as India and China.

Market Participants

The major players associated with the controlled release drug delivery market Capsugel, Orbis Biosciences, Inc., Pfizer, Inc, Merck and Co., Inc., Johnson and Johnson, Alkermes plc, Coating Place, Inc., Depomed, Inc., Corium International, Inc., and Aradigm Corporation. Most of these firms put stress on new product launch and mergers & acquisitions, technological expansion, and strategic partnership activities as part of their commercial growth strategies.


Related Reports

Tumor Necrosis Factor (TNF) Inhibitor Drugs Market (By Product: Simponi/Simponi Aria, Remicade, Enbrel, Cimzia, Humira, Biosimilars; By Application: Psoriatic Arthritis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Ulcerative Colitis, Ankylosing Spondylitis, Others; By Sales Channel: Online Pharmacies, Specialty Pharmacies, Hospital Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global TNF Inhibitor Drugs market is forecasted to grow at striking CAGR around 0.6% over the forecast time frame and reach around US$ 41 billion by 2026. TNF inhibitors or factor inhibitors of tumor necrosis are biological medicines extracted from human or animal tissue, most frequently used to preve

Scleroderma Therapeutics Market (By Drug Class: Immunosuppressors, Endothelin Receptor Antagonists, Phosphodiesterase 5 Inhibitors - PHA, Calcium Channel Blockers, Analgesic, Prostacyclin Analogues, Others; By Indication: Systemic, Localized) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global scleroderma therapeutics market is forecasted to grow at striking CAGR around 6.4% over the forecast time frame and reach around US$ 3.8 billion by 2026. It is an autoimmune rheumatic condition which causes the skin and connective tissues to get chronically hardened and tightened. However, it i

Orthopedic Biomaterials Market (By Material Type: Calcium Phosphate Cements, Ceramics & Bioactive Glasses, Polymers, Composites, Metal; By Application: Joint Replacement/Reconstruction, Orthopedic Implants, Viscosupplementation, Bio-resorbable Tissue Fixation, Orthobiologics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global orthopedic biomaterials market size is expected to reach around US$ 26 billion by 2026 growing at noteworthy CAGR around 10.0 % throughout the forecast period 2019 to 2026. Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For m

Oral Irrigator Market (By Type: Countertop, Cordless; By Application: Home, Dentistry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global oral irrigator market value is expected to reach around US$ 1 billion by 2026 growing at CAGR around 3.6% over the forecast time frame 2019 to 2026. The device used to remove plaque and debris from between teeth is dental water or oral water irrigation. This method is carried out with a pulse w

Irritable Bowel Syndrome Treatment Market (By Type: IBS-D [Viberzi, Xifaxan, Others], IBS-C [Amitiza, Linzess/Constella, Others]; By Product: Viberzi, Linzess/Constella, Xifaxan, Amitiza, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Irritable Bowel Syndrome Treatment market is expected to grow at noteworthy CAGR around 9.8 % throughout the forecast period and reach around US$ 3.4 billion by 2026. IBS is a gastrointestinal functional disorder of the intestine that is characterized by contractions of the colon muscle. The bi

Cart Summary